Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brexit Deal Rejection Sounds Alarm Bells For Pharma Industry

Executive Summary

The UK parliament’s decision to reject the Brexit deal could make the prospect of a no-deal exit more likely, although further votes today and on March 14 could see lawmakers rule out that option – at least for now – and opt instead for an extension of the Article 50 process. Either way, the certainty sought by industry, in particular the life sciences sector, is as far away as ever.

Advertisement

Related Content

UK Industry Skeptical Of Govt’s No-Deal Brexit Filing Expectations

Topics

Advertisement
UsernamePublicRestriction

Register

PS124914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel